JINDAL VINEET R. (Chief Financial Officer) purchased 5K shares of ONKURE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $37.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/26/2021ACC: 0001209191-21-053523
Officer· Chief Financial Officer
Since Apr 2021
+5K
Net shares
Net buyer
$37.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$7.44
Trade value
$37.18K
% of position
New position
8/25/2021
0.00→5K
Total
Net shares
+5K
Net value
$37.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2021 | P · Purchase | +5K | $7.44 | $37.18K | New position | 0.00 | 5K |
| Total | +5K | $37.18K | ||||||
Derivative Transactions0
No derivative transactions reported